companydata.dkcompanydata.dk

GSK 2023 ApS: Financial statements 2012

CVR: 43456415

Source: annual report 2012, Danish Business Authority

01/01/2012 – 31/12/2012

GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 3,146,974 and a net result of DKK 3,888,209. Equity in the 2012 report amounted to DKK 40,789,244. The solvency ratio was 72.1%.

Gross Profit
DKK 3,146,974
Profit/Loss
DKK 3,888,209
Equity
DKK 40,789,244
Total Assets
DKK 56,585,365

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GSK 2023 ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

Steen Roelsgaard leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Steen Roelsgaard has left the board of directors of GSK 2023 ApS.

Finn Sørensen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Finn Sørensen has left the board of directors of GSK 2023 ApS.

Ole Hedegaard Hansen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Ole Hedegaard Hansen has left the board of directors of GSK 2023 ApS.

Erik Leth Pedersen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Erik Leth Pedersen has left the board of directors of GSK 2023 ApS.

Tina Kastrup leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Tina Kastrup has left the board of directors of GSK 2023 ApS.

Susanne Nielsen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Susanne Nielsen has left the board of directors of GSK 2023 ApS.

Hanne Mortensen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Hanne Mortensen has left the board of directors of GSK 2023 ApS.

Peter Gregers Andersen leaves the board of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Peter Gregers Andersen has left the board of directors of GSK 2023 ApS.

Lisbeth Stenbro joins GSK 2023 ApS as directorFeb 17, 2012

As of February 17, 2012, Lisbeth Stenbro is registered as director of GSK 2023 ApS.

Brian Stenbro steps down as adm. dir. of GSK 2023 ApSFeb 17, 2012

As of February 17, 2012, Brian Stenbro has stepped down as adm. dir. of GSK 2023 ApS.

About GSK 2023 ApS

GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.

Source: annual report 2025, Danish Business Authority